Scientists Develop Programmable Chemotherapy to Destroy Cancer Cell DNA
Researchers have harnessed a bacterial CRISPR enzyme called Cas12a2 to function as a programmable chemotherapy, recognizing specific messenger RNAs in cancer cells and shredding their genomes to trigger self-destruction. Akribion Therapeutics is developing the technology to target HPV-related head and neck cancers, aiming for clinical trial data by 2030. The Molecular Kill Switch: How Cas12a2 … Read more